Hainan Poly Pharm (300630.SZ): Busulfex injection granted temporary approval by the US FDA.

Hainan Poly Pharm (300630.SZ) announced that the company recently received temporary approval from the Food and Drug Administration (FDA) of the United States for the injection of Brivudine. The indication for this drug is the treatment of partial onset seizures in patients aged 1 month and older.